|
Diabetes and Cardiovascular Disease
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease Daniele Versari, Elena Daghini, Agostino Virdis, Lorenzo Ghiadoni, and Stefano Taddei
Diabetes Care 2009;32 S314-S321 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S314
Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines Baptist Gallwitz
Diabetes Care 2009;32 S322-S325 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S322
The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice Oliver Schnell, Wolfgang Otter, and Eberhard Standl
Diabetes Care 2009;32 S326-S330 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S326
Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes Jaime A. Davidson and Christopher G. Parkin
Diabetes Care 2009;32 S331-S333 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S331
Glucose Control and Cardiovascular Disease: Is it important? No Ignacio Conget and Marga Giménez
Diabetes Care 2009;32 S334-S336 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S334
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No Sameer A. Kassem and Itamar Raz
Diabetes Care 2009;32 S337-S341 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S337
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes Cristina Bianchi, Roberto Miccoli, Giuseppe Daniele, Giuseppe Penno, and Stefano Del Prato
Diabetes Care 2009;32 S342-S348 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S342
Shifting the Disease Management Paradigm From Glucose: What are the pros? Alin Stirban, Diethelm Tschoepe, and Bernd Stratmann
Diabetes Care 2009;32 S349-S352 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S349
Shifting the Disease Management Paradigm From Glucose: What are the cons? Markolf Hanefeld, Stefan R. Bornstein, and Frank Pistrosch
Diabetes Care 2009;32 S353-S356 http://care.diabetesjournals.org/cgi/content/extract/32/suppl_2/S353
A Summary of the ADVANCE Trial Simon R. Heller and on behalf of the ADVANCE Collaborative Group
|